Retaglutide is a novel GLP-1 receptor agonist currently under investigation for the management of type 2 diabetes. This therapy works by stimulating the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring https://jesseqiuh752857.link4blogs.com/59827820/trelaglutide-exploring-a-new-option-for-chronic-diseases